Arkolith/Insider Trading/XERS/Form 4

Halkuff Dawn

DirectorXeris Biopharma Holdings, Inc. (XERS) · full profile →Form 4 · filed Aug 13, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$309K
Net Open-Market Flow
-$309K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 12, 2025Sell(S)43K$7.28$309K115K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001867096-25-000138) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML